High-Resolution Diffusion Tensor Imaging (DTI) of the Cervical Spinal Cord in the Setting of Spinal Cord Injury (SCI)
1 other identifier
observational
31
1 country
1
Brief Summary
The investigators propose a prospective study, designed to analyze the efficacy of High-Resolution Diffusion Tensor Imaging for accurately sensing white matter tracts in subjects with spinal cord injury. Study subjects will not be randomized, as treatment will follow the doctor's "standard of care." Patients will be selected and offered enrollment based upon the clinical diagnosis of spinal cord injury, either due to degenerative disease or trauma. Enrollment will be based on the chronology of patient presentation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 29, 2011
CompletedFirst Posted
Study publicly available on registry
August 2, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedMay 21, 2014
May 1, 2014
7 years
July 29, 2011
May 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
high-resolution DTI of cervical spinal cord
To determine the efficacy of high-resolution diffusion weighted pulse sequence with spatial resolution of 2.0 mm3 to confirm directionality and intactness of cervical spinal cord tracts in vivo in the setting of spinal cord injury and disease-free subjects.
2 years
Study Arms (2)
Control Group
* No diagnosis of cervical degenerative or traumatic disease * 30 to 80 years of age * Ability of volunteers to tolerate 1 hr examination
Disease (Non-healthy) Group
Cervical Spinal Cord: * Clinical and Radiographic evidence of cervical spondylotic myelopathy * 18 to 80 years of age * Safe and stable clinical scenario to undergo imaging * Awake, alert patient able to cooperate with physical examination * Give written informed consent prior to any testing under this protocol Degenerative Disease Group: * Have signs or symptoms consistent with spinal cord injury. * Be diagnosed with cervical spondylosis (degenerative disease). Traumatic Group: • A spinal cord injury associated with a traumatic event.
Eligibility Criteria
Study subjects will not be randomized, as treatment will follow the doctor's "standard of care." Patients will be selected and offered enrollment based upon the clinical diagnosis of spinal cord injury, either due to degenerative disease or trauma. Enrollment will be based on the chronology of patient presentation.
You may qualify if:
- Clinical and Radiographic evidence of cervical spondylotic myelopathy
- to 80 years of age
- Safe and stable clinical scenario to undergo imaging
- Awake, alert patient able to cooperate with physical examination
- Give written informed consent prior to any testing under this protocol
- No diagnosis of cervical degenerative or traumatic disease
- to 80 years of age
- Ability of volunteers to tolerate 1 hr examination
- Have signs or symptoms consistent with spinal cord injury.
- Be diagnosed with cervical spondylosis (degenerative disease).
- A spinal cord injury associated with a traumatic event.
You may not qualify if:
- Unsafe or unstable clinical scenario
- Prior cervical spine surgery
- History of neurological disease (stroke, multiple sclerosis, peripheral neuropathy, or other neurodegenerative conditions)
- Inability to comply with physical examination
- Contraindications to MRI imaging (metal debris, cardiac pacemaker, etc..)
- Pregnant women
- Inability to comply with physical examination
- Contraindications to MRI imaging (metal debris, cardiac pacemaker, etc..)
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Utah Orthopedics
Salt Lake City, Utah, 84108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brandon Lawrence, MD
University of Utah Orthopedics
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
July 29, 2011
First Posted
August 2, 2011
Study Start
May 1, 2007
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
May 21, 2014
Record last verified: 2014-05